The global Chloangiocarcinoma Therapeutics Market is expected to reach a market value of US$ 800 million in 2023 and a market value of US$ 975.20 million by 2033, with a CAGR of 2% from 2023 to 2033. Changes in bile duct anatomy caused by inflammatory bowel disease, as well as exposure to certain toxins and pollutants, have …